The US National Association of Chain Drug Stores and the National Community Pharmacists Association have formed the Coalition for Community Pharmacy Action as part of an effort to "unite the nation's 55,000 community pharmacies and create a greater defense" against what the groups describe as "threats" to the pharmacy industry and health care.
The CCPA, a Virginia-based not-for-profit company, aims to revise the Medicare Part D prescription drug benefit, oppose Medicaid reimbursement reductions and ensure TRICARE beneficiaries can continue to obtain prescriptions from community pharmacies. Bruce Roberts, chief executive of the NCPA, said: "the nation's community pharmacists - both independent and chains - have faced a series of threatening legislative and regulatory policies."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze